| Seifollah Azadi, | |
|
755 Research Pkwy Ste 450a, Oklahoma City, OK 73104-3629 | |
| (405) 822-2830 | |
| Not Available |
| Full Name | Seifollah Azadi |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology - Retina Specialist |
| Location | 755 Research Pkwy Ste 450a, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285373985 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0107X | Ophthalmology - Retina Specialist | 37D2252058 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Seifollah Azadi, 755 Research Pkwy Ste 450a, Oklahoma City, OK 73104-3629 Ph: (405) 822-2830 | Seifollah Azadi, 755 Research Pkwy Ste 450a, Oklahoma City, OK 73104-3629 Ph: (405) 822-2830 |
News Archive
In a report on the so-called REMEMBER (Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment) study - a 10-nation, randomized clinical trial of adult outpatients - investigators concluded that there was no added benefit of using four drugs for TB over just using one drug, isoniazid, to save lives in people with advanced HIV/AIDS.
Oncotarget published "Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib" which reported that this study investigated the association of the IGF/CTP score with overall survival and progression-free survival of HCC patients treated with sorafenib.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the International Society of Nephrology, the global medical society devoted to advancing kidney care worldwide, announced today that Elsevier will publish ISN's flagship journals, Kidney International and Kidney International Supplements, as of January 1, 2016.
Circulating tumor cells spread ovarian cancer through the bloodstream, homing in on a sheath of abdominal fatty tissue where it can grow and metastasize to other organs, scientists at The University of Texas MD Anderson Cancer Center report in Cancer Cell.
A new review highlights new developments in understanding the health effects of silica, and calls for action to reduce illness and death from silica exposure at work, including stronger regulations, heightened awareness and prevention, and increased attention to early detection of silicosis and lung cancer using low dose CT scanning.
› Verified 5 days ago
Vinay Ashok Shah, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9821 S May Ave Ste C, Oklahoma City, OK 73159 Phone: 405-691-0505 Fax: 405-691-0507 | |
Cynthia A Bradford, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-6060 Fax: 405-271-7873 | |
Jila Noorikolouri, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-6060 Fax: 405-271-3013 | |
Dr. Brian Keith Firestone, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-6060 Fax: 405-271-7873 | |
David W Parke Ii, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-1092 | |
Gary Waine Wilson, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 7101 Nw Expressway, Suite 335, Oklahoma City, OK 73132 Phone: 405-722-2020 Fax: 405-516-6126 | |
David W. Jackson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-1095 |